The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor

Published:2016-08-01 Issue:2 Volume:11 Page:88-94
ISSN:1574-8847
Container-title:Current Clinical Pharmacology
language:en
Short-container-title:CCP

Author:

Singh Harmanjit,Kaur Mandeep,K. Kakkar Ashish,Kumar Harish

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Integrase Enzyme: A Therapeutic Approach to Combat HIV Resistance;Mini-Reviews in Medicinal Chemistry;2020-03-30

2. Successful use of once‐daily high‐dose darunavir and dolutegravir in multidrug‐resistant HIV;Journal of Clinical Pharmacy and Therapeutics;2019-11-25

3. Is There a Safety Signal for Dolutegravir and Integrase Inhibitors During Pregnancy?;JAIDS Journal of Acquired Immune Deficiency Syndromes;2019-08-01

4. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice;Nature Communications;2019-07-02

5. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial;The Lancet Infectious Diseases;2018-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP